| abstract |
The invention provides compounds of formula (I), wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the description and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof. ; together with processes for its preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are microsomal prostaglandin E synthase-1 inhibitors. |